Do VERTIS-CV trial results question a class-effect of cardiovascular protection with sodium-glucose cotransporter 2 inhibitors?

被引:4
|
作者
Volpe, Massimo [1 ]
Patrono, Carlo [2 ,3 ]
机构
[1] FAHA Univ Rom Sapienza, Fac Med & Psicol, Rome, Italy
[2] Catholic Univ, Sch Med, Pharmacol, Rome, Italy
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1093/eurheartj/ehaa891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4232 / 4233
页数:3
相关论文
共 50 条